174 related articles for article (PubMed ID: 18586578)
21. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
[TBL] [Abstract][Full Text] [Related]
22. Bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Papageorgiou T; Papastergiou C; Tsituridis I; Koliouskas D
Turk J Pediatr; 2006; 48(2):101-4. PubMed ID: 16848106
[TBL] [Abstract][Full Text] [Related]
23. Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia.
Arikoski P; Komulainen J; Voutilainen R; Riikonen P; Parviainen M; Tapanainen P; Knip M; Kröger H
J Pediatr Hematol Oncol; 1998; 20(3):234-40. PubMed ID: 9628435
[TBL] [Abstract][Full Text] [Related]
24. Prevention of osteoporosis as a consequence of aromatase inhibitor therapy in postmenopausal women with early breast cancer: rationale and design of a randomized controlled trial.
Kilbreath S; Refshauge KM; Beith J; Ward L; Sawkins K; Paterson R; Clifton-Bligh P; Sambrook PN; Simpson JM; Nery L
Contemp Clin Trials; 2011 Sep; 32(5):704-9. PubMed ID: 21570487
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D supplementation and bone mineral density in early postmenopausal women.
Cooper L; Clifton-Bligh PB; Nery ML; Figtree G; Twigg S; Hibbert E; Robinson BG
Am J Clin Nutr; 2003 May; 77(5):1324-9. PubMed ID: 12716689
[TBL] [Abstract][Full Text] [Related]
26. Bone mineral density, vitamin D status, and calcium intake in healthy female university students from different socioeconomic groups in Turkey.
Ersoy B; Kizilay DÖ; Yilmaz SK; Taneli F; Gümüşer G
Arch Osteoporos; 2018 Dec; 13(1):135. PubMed ID: 30515581
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
28. The Association of Oral Vitamin D and Calcium Supplementation With Bone Mineral Density in Pediatric Acute Lymphoblastic Leukemia Patients.
Demirsoy U; Sarper N; Aylan Gelen S; Zengin E; Kum T; Demir H
J Pediatr Hematol Oncol; 2017 May; 39(4):287-292. PubMed ID: 28234736
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial.
Overton ET; Chan ES; Brown TT; Tebas P; McComsey GA; Melbourne KM; Napoli A; Hardin WR; Ribaudo HJ; Yin MT
Ann Intern Med; 2015 Jun; 162(12):815-24. PubMed ID: 26075752
[TBL] [Abstract][Full Text] [Related]
30. Bone mineral density in young adult survivors of acute lymphoblastic leukemia.
Thomas IH; Donohue JE; Ness KK; Dengel DR; Baker KS; Gurney JG
Cancer; 2008 Dec; 113(11):3248-56. PubMed ID: 18932250
[TBL] [Abstract][Full Text] [Related]
31. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Tillmann V; Darlington AS; Eiser C; Bishop NJ; Davies HA
J Bone Miner Res; 2002 Jun; 17(6):1073-80. PubMed ID: 12054163
[TBL] [Abstract][Full Text] [Related]
32. Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial.
Soo I; Siffledeen J; Siminoski K; McQueen B; Fedorak RN
J Crohns Colitis; 2012 Aug; 6(7):777-86. PubMed ID: 22398088
[TBL] [Abstract][Full Text] [Related]
33. Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemia.
Gawade PL; Ness KK; Sharma S; Li Z; Srivastava DK; Spunt SL; Nottage K; Krasin MJ; Hudson MM; Kaste SC
J Cancer Surviv; 2012 Dec; 6(4):388-97. PubMed ID: 22956305
[TBL] [Abstract][Full Text] [Related]
34. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study.
Bernstein CN; Seeger LL; Anton PA; Artinian L; Geffrey S; Goodman W; Belin TR; Shanahan F
Aliment Pharmacol Ther; 1996 Oct; 10(5):777-86. PubMed ID: 8899087
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D nutritional status and bone turnover markers in childhood acute lymphoblastic leukemia survivors: A PETALE study.
Delvin E; Alos N; Rauch F; Marcil V; Morel S; Boisvert M; Lecours MA; Laverdière C; Sinnett D; Krajinovic M; Dubois J; Drouin S; Lefebvre G; Samoilenko M; Nyalendo C; Cavalier E; Levy E
Clin Nutr; 2019 Apr; 38(2):912-919. PubMed ID: 29503055
[TBL] [Abstract][Full Text] [Related]
36. Eldecalcitol increases bone mineral density in Chinese osteoporotic patients without vitamin D or calcium supplementation.
Jiang Y; Tang H; Ma X; Cheng Q; Lin H; Jin X; Zhang Z; Yu W; He S; Kobayashi T; Uehara S; Matsumoto T; Xia W
J Bone Miner Metab; 2019 Nov; 37(6):1036-1047. PubMed ID: 31087185
[TBL] [Abstract][Full Text] [Related]
37. Long-Term Impact of Calcium and Vitamin D Supplementation on Bone Density in HIV
Faber J; Bech A; van Bentum P; Gisolf J; Hassing RJ; de Boer H
AIDS Res Hum Retroviruses; 2020 Jan; 36(1):58-64. PubMed ID: 31523978
[TBL] [Abstract][Full Text] [Related]
38. Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis.
Haworth CS; Jones AM; Adams JE; Selby PL; Webb AK
J Cyst Fibros; 2004 Dec; 3(4):233-6. PubMed ID: 15698940
[TBL] [Abstract][Full Text] [Related]
39. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
[TBL] [Abstract][Full Text] [Related]
40. Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation.
van Bodegraven AA; Bravenboer N; Witte BI; Dijkstra G; van der Woude CJ; Stokkers PC; Russel MG; Oldenburg B; Pierik M; Roos JC; van Hogezand RA; Dik VK; Oostlander AE; Netelenbos JC; van de Langerijt L; Hommes DW; Lips P;
Gut; 2014 Sep; 63(9):1424-30. PubMed ID: 24146170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
